» Articles » PMID: 24502918

Entamoeba Histolytica-secreted Cysteine Proteases Induce IL-8 Production in Human Mast Cells Via a PAR2-independent Mechanism

Overview
Journal Parasite
Specialty Parasitology
Date 2014 Feb 8
PMID 24502918
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Entamoeba histolytica is an extracellular tissue parasite causing colitis and occasional liver abscess in humans. E. histolytica-derived secretory products (SPs) contain large amounts of cysteine proteases (CPs), one of the important amoebic virulence factors. Although tissue-residing mast cells play an important role in the mucosal inflammatory response to this pathogen, it is not known whether the SPs induce mast cell activation. In this study, when human mast cells (HMC-1 cells) were stimulated with SPs collected from pathogenic wild-type amoebae, interleukin IL-8 mRNA expression and production were significantly increased compared with cells incubated with medium alone. Inhibition of CP activity in the SPs with heat or the CP inhibitor E64 resulted in significant reduction of IL-8 production. Moreover, SPs obtained from inhibitors of cysteine protease (ICP)-overexpressing amoebae with low CP activity showed weaker stimulatory effects on IL-8 production than the wild-type control. Preincubation of HMC-1 cells with antibodies to human protease-activated receptor 2 (PAR2) did not affect the SP-induced IL-8 production. These results suggest that cysteine proteases in E. histolytica-derived secretory products stimulate mast cells to produce IL-8 via a PAR2-independent mechanism, which contributes to IL-8-mediated tissue inflammatory responses during the early phase of human amoebiasis.

Citing Articles

Host spatiotemporal overlap in a park with high endemicity of .

Visscher D, Toews E, Pattison J, Walker P, Kemna C, Musiani M Front Parasitol. 2025; 2():1161108.

PMID: 39816820 PMC: 11732005. DOI: 10.3389/fpara.2023.1161108.


Extracellular Cysteine Proteases of Key Intestinal Protozoan Pathogens-Factors Linked to Virulence and Pathogenicity.

Arguello-Garcia R, Carrero J, Ortega-Pierres M Int J Mol Sci. 2023; 24(16).

PMID: 37629029 PMC: 10454693. DOI: 10.3390/ijms241612850.


Characterization of Extracellular Vesicles Secreted by a Clinical Isolate of and Identification of Immunogenic Components within Their Protein Cargo.

Retana Moreira L, Steller Espinoza M, Chacon Camacho N, Cornet-Gomez A, Saenz-Arce G, Osuna A Biology (Basel). 2022; 11(7).

PMID: 36101365 PMC: 9312180. DOI: 10.3390/biology11070983.


Cathepsin B Induces a Pro-Inflammatory Immune Response in BV-2 Microglial Cells via NF-κB and AP-1 Dependent-MAPK Signaling Pathway.

Le H, Kang J, Vo T, Na B Int J Mol Sci. 2022; 23(15).

PMID: 35955520 PMC: 9369353. DOI: 10.3390/ijms23158388.


Signaling Role of NADPH Oxidases in ROS-Dependent Host Cell Death Induced by Pathogenic Entamoeba histolytica.

Lee Y, Sim S, Kim K, Shin M Korean J Parasitol. 2022; 60(3):155-161.

PMID: 35772733 PMC: 9256287. DOI: 10.3347/kjp.2022.60.3.155.


References
1.
Leippe M, Ebel S, Schoenberger O, Horstmann R, MULLER-EBERHARD H . Pore-forming peptide of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1991; 88(17):7659-63. PMC: 52361. DOI: 10.1073/pnas.88.17.7659. View

2.
Trejo J . Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking. J Pharmacol Exp Ther. 2003; 307(2):437-42. DOI: 10.1124/jpet.103.052100. View

3.
Galli S, Kalesnikoff J, Grimbaldeston M, Piliponsky A, Williams C, Tsai M . Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005; 23:749-86. DOI: 10.1146/annurev.immunol.21.120601.141025. View

4.
Espinosa-Cantellano M, Martinez-Palomo A . Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev. 2001; 13(2):318-31. PMC: 100155. DOI: 10.1128/CMR.13.2.318. View

5.
McCoy J, Mann B, Petri Jr W . Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect Immun. 1994; 62(8):3045-50. PMC: 302925. DOI: 10.1128/iai.62.8.3045-3050.1994. View